Detection of NDMA in ranitidine drugs (Zantac) led to a recent recall. While the carcinogenic effects in humans are not conclusive, NDMA is considered a probable human carcinogen
Company that detected impurities in ranitidine drugs says FDA testing methodology is insufficient, while FDA counters that the company’s testing method was inaccurate
The results of a recent study raise questions about whether current surface detection methods allow people living inside a former meth house to understand the extent of contamination that's present,
Despite significant investments into cancer research over the last decades, 1.7 million new cancer cases were estimated in the U.S. in 2017
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.